Lorne Tyrrell named one of Alberta's Most Influential

    Latest accolade for Lorne Tyrrell places him in Alberta's top influencers.

    By Amy Hewko on July 2, 2015

    On June 29, 2015, Alberta Venture listed Lorne Tyrrell as one of Alberta's 50 most influential people. Tyrrell, a long-lasting member of the Faculty of Medicine & Dentistry, is a world-renown virologist for his contributions to the development of lamivudine, an oral drug that treats the Hepatitis B virus. This work resulted in a major collaboration with Glaxo Canada (now GlaxoSmithKline).

    Tyrrell has played many important roles within the University of Alberta, first as a student, then as a professor, mentor, researcher, director, chair and dean. He was instrumental in securing funding for the Li Ka Shing Institute of Virology, where he is currently director.

    In addition to his role within the university, he has also sat on many major health-care committees at the national and provincial level, participated in many editorial reviews, and has been involved with more than 10 biotechnology companies as a member of the boards of directors, scientific advisory boards or in leadership roles.

    Learn more about Tyrrell's involvement at the University of Alberta below.